Market Coupling Results definition

Market Coupling Results means the final market coupling results following
Sample 1Sample 2
Market Coupling Results means the results calculated by the Algorithm containing Single Day-Ahead Coupling flows, net positions, and prices. The Market Coupling Results are verified and validated by the Parties; Market Coupling Steering Committee or “MC SC” means the steering committee as referred to in Article 12;
Sample 1Sample 2
Market Coupling Results means the results of the 4M MC Market Coupling, calculated in accordance with Article 6 and consisting of, for each PX (added and detailed according to the PCR MC results standard, as agreed between the PXs involved in 4M MC) as well as for each TSO (TSO Results, as agreed between the 4M MC Parties): - Market Clearing Price in each Bidding Area; - Trading position of each Market Area (Net Positions); - Cross-border Exchanges; - Accepted block bids.
Sample 1

Examples of Market Coupling Results in a sentence

  • A Full Decoupling is a situation where it is not possible to allocate the CZCs, for a specific day, via the implicit allocation process, where a time limit has been reached and the Market Coupling Results cannot be published before the Full Decoupling Deadline.

  • The funding secured through this grant cover salary, benefits, and general expenses incurred by the Washington Coast Sustainable Salmon Partnership and the Lead Entities associated with this regional organization .

  • A Full Decoupling is a situation where it is not possibleto allocate the CZCs , for a specific day, via the implicit allocation process, where a time limit has been reached and the Market Coupling Results cannot be published before the Full Decoupling Deadline.

  • The Parties will work in good faith to clarify the ownership of the SIDC/IDA Preliminary Market Coupling Results and SIDC/IDA Market Coupling Results in the occurrence of Partial Decoupling in Bidding Areas with two or more Operational NEMOs via an amendment to this Agreement at the first available opportunity.

  • The verification consists of the validation of the Market Coupling Results against the Cross-Zonal Capacities and optional Allocation Constraints.Once the Market Coupling Results are confirmed by the Verification Systems, the Final Confirmation is forwarded by the NEMO to the PMB in order to generate and distribute the Global Final Confirmation to all NEMOs (cf.

  • When the previous conditions are fulfilled, the Algorithm will validate the input data and then automatically start the Algorithm execution.This procedure ends when the PMB indicates that the Market Coupling Results calculation has finished successfully.

  • When the price limit is reached, it can be solved by updating the order book depending on the market situation.Once the NEMOs receive the Market Coupling Results, checks are performed according to local procedures.

  • No reaction from a Party is considered as a deemed acceptance of the Market Coupling Results.

  • Market Coupling Results cannot be published prior to an agreed time in the Procedures.

  • A Full Decoupling known during the Daily Market Coupling Session will be declared from the PCR Incident Committee (IC) of MRC in case the Market Coupling Results cannot be published within the fixed time limit (currently 13:50 D-1) due to issues detected only during the current Market Coupling Session.

Related to Market Coupling Results

  • COVID-19 test means a viral test for SARS-CoV-2 that is:

  • Project Results means all data and results of the Project.

  • Forecast GDP means the average forecast for British Columbia’s real GDP growth made by the Economic Forecast Council and as reported in the annual February budget of the government;

  • Major Market Countries means the United States, Japan, England, Germany, France, Italy and Spain.

  • Yearly (1/Year) sampling frequency means the sampling shall be done in the month of September, unless specifically identified otherwise in the effluent limitations and monitoring requirements table.

  • Quarterly (1/Quarter) sampling frequency means the sampling shall be done in the months of March, June, August, and December, unless specifically identified otherwise in the Effluent Limitations and Monitoring Requirements table.

  • Product Schedule means the “Product Schedule” that forms part of the Contract.

  • Yearly (1/Year) sampling frequency means the sampling shall be done in the month of September, unless specifically identified otherwise in the effluent limitations and monitoring requirements table.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Semi-annual (2/Year) sampling frequency means the sampling shall be done during the months of June and December, unless specifically identified otherwise.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Quarterly (1/Quarter) sampling frequency means the sampling shall be done in the months of March, June, August, and December, unless specifically identified otherwise in the Effluent Limitations and Monitoring Requirements table.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Monitoring Indicator means a measure of HSP performance that may be monitored against provincial results or provincial targets, but for which no Performance Target is set;

  • Explanatory Indicator means a measure that is connected to and helps to explain performance in a Performance Indicator or a Monitoring Indicator. An Explanatory Indicator may or may not be a measure of the HSP’s performance. No Performance Target is set for an Explanatory Indicator;

  • Major Market Country means each of the United States, Japan, France, Germany, Italy, Spain and the United Kingdom.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Research Results means any technical result acquired based on the Collaborative Research, including, but not limited to, any invention, idea, design, copyrightable work and know-how which relates to the purpose of the Collaborative Research.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Catalog Pricing and Pricing Requirements

  • Sound level meter means an instrument which includes a microphone, amplifier, RMS detector, integrator or time averager, output meter, and weighting networks used to measure sound pressure levels.

  • Semi-annual (2/Year) sampling frequency means the sampling shall be done during the months of June and December, unless specifically identified otherwise.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Parameter means a measurable factor of a liquid, gas, or solid such as temperature, pH, length, or elevation, and includes constituents of the liquid, gas, or solid.

  • Phase I Trial means a Clinical Trial, the principal purpose of which is preliminary determination of safety of an investigational product in healthy individuals or patients or that otherwise meets the requirements described in 21 C.F.R. §312.21(a), or similar Clinical Trial in a country other than the United States.